Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Schizophrenia Research|January 26, 2016
Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and JapanAlex Hofer, Yuya Mizuno, Beatrice Frajo-Apor, et al.
The American Journal of Psychiatry|November 6, 2018
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode PsychosisJian-Ping Zhang, Delbert Robinson, Jin Yu, et al.
Schizophrenia Research|December 24, 2013
Facial affect recognition in symptomatically remitted patients with schizophrenia and bipolar disorderNursen Yalcin-Siedentopf, Christine M Hoertnagl, Falko Biedermann, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|January 4, 2023
Multinational perspectives on changes to psychiatric care during the COVID-19 pandemic: a survey of practicing psychiatristsAbhishek Jaywant, Wolfgang Aulitzky, Jimmy Avari, et al.
Schizophrenia Bulletin|April 30, 2014
Schizophrenia--time to commit to policy changeW Wolfgang Fleischhacker, Celso Arango, Paul Arteel, et al.
Psychological Medicine|July 30, 2025
AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trialsSergio Mena, Fiona Coutts, Jana von Trott, et al.
The Lancet. Psychiatry|February 21, 2021
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 studyW Wolfgang Fleischhacker, Jana Podhorna, Martina Gröschl, et al.
Clinical Schizophrenia & Related Psychoses|February 26, 2015
Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind StudiesJohn M Kane, Raymond Sanchez, Ross A Baker, et al.
Schizophrenia Research|October 6, 2014
Effects of aripiprazole once-monthly on domains of personal and social performance: results from 2 multicenter, randomized, double-blind studiesW Wolfgang Fleischhacker, Ross A Baker, Anna Eramo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2016
Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment settingAlexandra Kaufmann, Fabienne Wartelsteiner, Nursen Yalcin-Siedentopf, et al.
Pageof 18